Short interest for GUMM
Date # Short Avg Vol Days to cover
01/99 847,179 75,918 11.16
12/98 827,658 49,164 16.83
11/98 941,469 66,056 14.25
10/98 901,925 63,848 14.13
09/98 824,679 48,369 17.05
08/98 749,182 82,587 9.07
Note: the above data reports for aproximatly the 20th of the prior month to the 20th of the month indicated
Monthly (calender) stock performance
Month Open High Low Close Volume Adj Close
Jan 1999 7.75 15.0625 7.75 11.875 269,200 11.875
Dec 1998 7.125 7.75 6.25 7.6875 49,100 7.6875
Nov 1998 7.125 8.375 6.375 6.75 73,200 6.75
Oct 1998 7.5 7.625 5 7.125 55,100 7.125
Sep 1998 7.75 9 7.125 7.5 50,600 7.5
Aug 1998 8 9.5 7.1875 7.5 60,500 7.5
While GUMM may pop on news etc..., don't forget that GUMM's finnancial's are poor, with a price to book ratio of 16 and a price to sales of 14 and it isn't making money yet. I would venture a guess that GUMM will be lining up a private placement (terms, dilution, amount??) as they are undercapitalized. Lots of questions about business side apart from the product discussion. Profit, revenue growth and finnancial strength determine the price of a stock over time, IF (it's not a forgone conclusion) Zicam becomes a success what will it cost to create the sucess (ads, shelf placement costs, receivables, inventory), what will GUMM get for this (gross margin and profit) and how long will it take?
|
